A major responder to ipilimumab and nivolumab in metastatic uveal melanoma with concomitant autoimmunity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A major responder to ipilimumab and nivolumab in metastatic uveal melanoma with concomitant autoimmunity

Published:2017-01 Issue:6 Volume:30 Page:558-562
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:Pigment Cell Melanoma Res.

Author:

Chan Pui Ying¹^ORCID,Hall Peter¹,Hay Gordon²³,Cohen Victoria M. L.²⁴,Szlosarek Peter W.¹⁵

Affiliation:

1. Department of Medical Oncology; St Bartholomew's Hospital; London UK

2. Department of Ocular Oncology; Moorfields Eye Hospital; London UK

3. UCL Institute of Ophthalmology; London UK

4. Department of Ocular Oncology; St Bartholomew's Hospital; London UK

5. Centre for Molecular Oncology; Barts Cancer Institute; London UK

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pcmr.12607/fullpdf

Reference34 articles.

1. Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: A systematic review;Abdel-Rahman;Expert Review of Anticancer Therapy,2017

2. Vitiligo or halo nevi occurring in two patients with choroidal melanoma;Albert;Archives of Dermatology,1982

3. Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies;Algazi;Cancer,2016

4. Effectiveness of treatments for metastatic uveal melanoma;Augsburger;American Journal of Ophthalmology,2009

5. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma;Azimi;Journal of Clinical Oncology,2012

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors-induced diabetes mellitus (review);Endocrine;2024-07-03

2. Pembrolizumab induced type 1 diabetes mellitus in a patient with metastatic melanoma and literature review on steroids as a treatment option;Journal of Oncology Pharmacy Practice;2024-03-28

3. Clinically Approved Monoclonal Antibodies–based Immunotherapy: Association With Glycemic Control and Impact Role of Clinical Pharmacist for Cancer Patient Care;Clinical Therapeutics;2024-01

4. Vogt-Koyanagi-Harada-like Syndrome and Electronegative Electroretinogram after Nivolumab Therapy for Metastatic Cutaneous Melanoma: A Case Report;The Open Ophthalmology Journal;2023-03-08

5. Ocular adverse events associated with immune checkpoint inhibitors, a scoping review;Journal of Ophthalmic Inflammation and Infection;2023-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3